These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe. Bai Z, Gao M, Zhang H, Guan Q, Xu J, Li Y, Qi H, Li Z, Zuo D, Zhang W, Wu Y. Cancer Lett; 2017 Aug 28; 402():81-92. PubMed ID: 28576750 [Abstract] [Full Text] [Related]
3. Overcoming resistance to mitochondrial apoptosis by BZML-induced mitotic catastrophe is enhanced by inhibition of autophagy in A549/Taxol cells. Bai Z, Gao M, Xu X, Zhang H, Xu J, Guan Q, Wang Q, Du J, Li Z, Zuo D, Zhang W, Wu Y. Cell Prolif; 2018 Aug 28; 51(4):e12450. PubMed ID: 29493085 [Abstract] [Full Text] [Related]
4. A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro. Cai P, Lu P, Sharom FJ, Fang WS. Cancer Lett; 2013 Dec 01; 341(2):214-23. PubMed ID: 23941826 [Abstract] [Full Text] [Related]
5. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction. Kebsa W, Lahouel M, Rouibah H, Zihlif M, Ahram M, Abu-Irmaileh B, Mustafa E, Al-Ameer HJ, Al Shhab M. Anticancer Agents Med Chem; 2018 Dec 01; 18(9):1330-1337. PubMed ID: 30088453 [Abstract] [Full Text] [Related]
6. CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells. Dinić J, Ríos-Luci C, Karpaviciene I, Cikotiene I, Fernandes MX, Pešić M, Padrón JM. Invest New Drugs; 2020 Jun 01; 38(3):584-598. PubMed ID: 31177401 [Abstract] [Full Text] [Related]
8. DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells. Podolski-Renić A, Banković J, Dinić J, Ríos-Luci C, Fernandes MX, Ortega N, Kovačević-Grujičić N, Martín VS, Padrón JM, Pešić M. Eur J Pharm Sci; 2017 Jul 15; 105():159-168. PubMed ID: 28502672 [Abstract] [Full Text] [Related]
9. Morin reverses P-glycoprotein-mediated multidrug-resistance in KBChR-8-5 cancer cell lines. Zhao Y, Xu S, Hao W, Fu Y. Cell Biochem Funct; 2024 Jul 15; 42(5):e4083. PubMed ID: 38938150 [Abstract] [Full Text] [Related]
10. Identification of a lathyrane-type diterpenoid EM-E-11-4 as a novel paclitaxel resistance reversing agent with multiple mechanisms of action. Liu Q, Cai P, Guo S, Shi J, Sun H. Aging (Albany NY); 2020 Feb 28; 12(4):3713-3729. PubMed ID: 32108588 [Abstract] [Full Text] [Related]
11. Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer Cells. Aldonza MB, Hong JY, Bae SY, Song J, Kim WK, Oh J, Shin Y, Lee SH, Lee SK. PLoS One; 2015 Feb 28; 10(6):e0127841. PubMed ID: 26098947 [Abstract] [Full Text] [Related]
12. TM2, a novel semi-synthetic taxoid, exerts anti-MDR activity in NSCLC by inhibiting P-gp function and stabilizing microtubule polymerization. Jia L, Gao X, Fang Y, Zhang H, Wang L, Tang X, Yang J, Wu C. Apoptosis; 2022 Dec 28; 27(11-12):1015-1030. PubMed ID: 36107354 [Abstract] [Full Text] [Related]
13. MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27. Pai HC, Kumar S, Shen CC, Liou JP, Pan SL, Teng CM. PLoS One; 2015 Dec 28; 10(4):e0123819. PubMed ID: 25874627 [Abstract] [Full Text] [Related]
14. Novel Heat Shock Protein 90 Inhibitors Suppress P-Glycoprotein Activity and Overcome Multidrug Resistance in Cancer Cells. Dinić J, Podolski-Renić A, Jovanović M, Musso L, Tsakovska I, Pajeva I, Dallavalle S, Pešić M. Int J Mol Sci; 2019 Sep 16; 20(18):. PubMed ID: 31527404 [Abstract] [Full Text] [Related]
15. The Dichloromethane Fraction of Vernonia cinerea Impart Pro-Apoptotic, Genotoxic, Cell Cycle Arrest, and Drug Efflux Inhibitory Effects on Human Adenocarcinoma Cells. Beeran AA, Udupa N, Maliyakkal N. Recent Pat Anticancer Drug Discov; 2020 Sep 16; 15(3):239-256. PubMed ID: 32838722 [Abstract] [Full Text] [Related]
16. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents. Qian J, Xia M, Liu W, Li L, Yang J, Mei Y, Meng Q, Xie Y. Eur J Pharmacol; 2019 Jun 05; 852():231-243. PubMed ID: 30959046 [Abstract] [Full Text] [Related]
17. Identification and optimization of biphenyl derivatives as novel tubulin inhibitors targeting colchicine-binding site overcoming multidrug resistance. Cheng B, Zhu G, Meng L, Wu G, Chen Q, Ma S. Eur J Med Chem; 2022 Jan 15; 228():113930. PubMed ID: 34794817 [Abstract] [Full Text] [Related]
18. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin. Li H, Krstin S, Wink M. Phytomedicine; 2018 Nov 15; 50():213-222. PubMed ID: 30466981 [Abstract] [Full Text] [Related]
19. YAN, a novel microtubule inhibitor, inhibits P-gp and MRP1 function and induces mitotic slippage followed by apoptosis in multidrug-resistant A549/Taxol cells. Gao M, Liu T, Li J, Guan Q, Wang H, Yan S, Li Z, Zuo D, Zhang W, Wu Y. Toxicol In Vitro; 2020 Dec 15; 69():104971. PubMed ID: 32805372 [Abstract] [Full Text] [Related]
20. Tangeretin, a citrus pentamethoxyflavone, antagonizes ABCB1-mediated multidrug resistance by inhibiting its transport function. Feng SL, Yuan ZW, Yao XJ, Ma WZ, Liu L, Liu ZQ, Xie Y. Pharmacol Res; 2016 Aug 15; 110():193-204. PubMed ID: 27058921 [Abstract] [Full Text] [Related] Page: [Next] [New Search]